Abstract:Introduction: Sepsis is a frequent complication in critically ill patients. Patients may require control of the source of infection, removal of pathogens and damaged cells, and organ support. Often, these targets can be achieved through the utilization of extracorporeal therapies including hemoperfusion for the adsorption of cytokines and other circulating mediators. On extracorporeal organ support, patients are generally treated with antibiotic therapy, and vancomycin is one of the most commonly used antibiotics. Because of the aspecific nature of adsorption, antibiotics can be removed from the circulation, leading to altered plasma levels and requiring prescription adjustment. The aim was to define the amount of vancomycin adsorbed by a sorbent cartridge (HA380, Jafron, China) during hemoperfusion and to establish possible strategies to maintain an effective plasma level in critically ill patients undergoing extracorporeal therapies. Methods: In vitro experiments with incremental concentrations of vancomycin in the test solution (500 and 1,000 mL) were carried out in a recirculation circuit until sorbent saturation was observed. A maximum of 10 g of vancomycin were injected and mini-modules containing 25 g of dry resin were utilized. Results: In different experiments with various concentration of vancomycin, a maximum amount of 244 mg/g of sorbent was adsorbed reaching saturation between 60 and 80 min from the beginning of the experiments. The kinetics of adsorption appears to be governed by a Langmuir-like isotherm with maximal removal speed in the early minutes and a plateau after 60 min. Discussion/conclusion: HA380 adsorbs significant amounts of vancomycin. Adjusting the achieved results with the experimental mini-module to a full-scale cartridge, a total of 25 g of antibiotic can be removed. This might have affected outcome results in clinical trials. This suggests prescribing administration to critically ill patients requiring hemoperfusion, immediately after or in the inter-session time window. In case of administration during hemoperfusion, adequate adjustment and plasma level monitoring is strongly recommended.

Effect of Mechanical Vibration on Kinetics of Solute Adsorption

Vancomycin Adsorption during in vitro Model of Hemoperfusion with Mini-Module of HA380 Cartridge

Adsorption Mass Transfer Zone of Vancomycin in Cartridges With Styrene-Divinylbenzene Sorbent

Zwitterionic Polymers As High-Performance Coatings for Hemoperfusion Adsorbents and Their Chemisorption of Protein-Bound Toxins Through Computational Simulations

Vancomycin and Gentamicin Removal with the HA380 Cartridge during Experimental Hemoadsorption

Blood Flow Distribution in Sorbent Beds: Analysis of a new Sorbent Device for Hemoperfusion

Study on Experiment in Vitro of Polyvinylidene Fluoride Fiber Used for Endotoxin Adsorption

The Effect of Mechanically-Generated Vibrations on the Efficacy of Hemodialysis; Assessment of Patients' Safety: Preliminary Reports

In vitro Removal of Therapeutic Drugs with a Novel Adsorbent System

[The effect of increasing ventral movement on the small solutes transport during peritoneal dialysis]

Biocompatibility and Cytotoxic Evaluation of New Sorbent Cartridges for Blood Hemoperfusion

Effect of adsorbate viscoelasticity on dynamical responses of laminated microcantilever resonators

Rationale for Adsorption in Extracorporeal Blood Purification

Effects of Hemoadsorption with a Novel Adsorbent on Sepsis: In vivo and in vitro Study

Application of therapeutic ultrasonic waves across the dialyzer membrane: A pilot study on the impact on dialyzer clearance and safety

Emerging technologies in extracorporeal treatment: focus on adsorption

Convection-Diffusion-Adsorption Model for the Description of the Analyte-Binding Reactions on a Membrane

Adsorption Dynamics of Uremic Toxins to Cyclodextrin-Coated Magnetic Nano-Adsorbents

Predicting the Impact of Dialyzer Choice and Binder Dialysate Flow Rate on Bilirubin Removal

The effect of solute adsorption on vapor pressure osmometry measurement

Does the cytokine adsorber CytoSorb® reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study